Wyost and Jubbonti are interchangeable with Xgeva/Prolia and are approved for all of the same indications in bone cancer and osteoporosis.

In this video, Erica L. Mayer, MD, MPH, discusses the SERENA-6 study, which assessed the efficacy of switching to camizestrant plus a CDK 4/6 inhibitor vs. continuing standard treatment among patients ...

A program where interested staff members receive additional training on cancer treatment effects and pet care, becoming ...

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study ...

The development of a new lump in the breast or armpit is the most common initial symptom of breast cancer, according to the Centers for Disease Control and Prevention. But for millions of ...

About a month ago, I woke up without hearing in my left ear. I initially suspected a wax blockage or a blocked eustachian ...

Recently, to my surprise, I came down with bladder cancer. I am a healthy 66-year-old man who is 5 feet, 11 inches tall, 215 ...